Detection of transforming growth factor-β1 in dermal lesions of different clinical forms of leprosy

American Journal of Pathology

Volumn 148, Issue 3, 1996, Pages 911-917

  Goulart, Isabela M B ^a   Figueiredo, Florêncio ^a   Coimbra, Terezila ^a   Foss, Norma T ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BIOPSY; BORDERLINE LEPROSY; HUMAN; IMMUNOHISTOCHEMISTRY; LEPROMATOUS LEPROSY; METABOLISM; PATHOLOGY; SKIN; TUBERCULOID LEPROSY;

BIOPSY; HUMANS; IMMUNOHISTOCHEMISTRY; LEPROSY, BORDERLINE; LEPROSY, LEPROMATOUS; LEPROSY, TUBERCULOID; SKIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030091653     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Ridley DS, Jopling WH: Classification of leprosy according to immunity: a five group system Int J Lepr 1966, 34:255-273
2. Bloom BR, Mehra V- Immunological unresponsiveness in leprosy, Immunol Rev 1984, 80.5-28
3. Modlin RL, Hofman FM, Taylor CR, Rea TH T lymphocytes subsets in the skin lesions of patients with leprosy J Am Acad Dermatol 1983, 8:182-189
4. Narayanan RB, Bhutani LK, Sharma AK, Nath I: T-cell subsets in leprosy lesions: in situ characterization using monoclonal antibodies. Clin Exp Immunol 1983, 51: 421-429
5. Van Voorhis WC, Kaplan G, Sarno EN, Horwitz MA, Steinman RM. Levis WR, Nogueira N, Hair LS, Gattass CR, Arrick BA, Cohn ZA: The cutaneous infiltrates of leprosy, cellular characteristics and the predominant T-cell phenotypes. N Engl J Med 1982, 307:1593-1597
6. Modlin RL, Hofman FM, Meyer PR, Sharma OP, Taylor CR, Rea TH. In situ demonstration of T lymphocyte subsets in granulomatous inflammation, leprosy, rhinosclerorna and sarcoidosis. Clin Exp Immunol 1983, 51 430-438
7. Modlin RL, Mehra V, Wong L, Fujimiya Y, Chang W-C, Horwitz DA, Bloom BR, Rea TH, Pattengale PK: Suppressor T lymphocyte from lepromatous leprosy skin lesions J Immunol 1986, 137.2831-2834
8. Ridley DS, Job CK The pathology of leprosy. Leprosy. Edited by RC Hastings. New York, Churchill Livingstone, 1985, pp 100-133
9. Modlin RL, Melancon-Kaplan J, Young SMM, Pirmez C, Kino H, Convit J, Rea TH, Bloom BR: Learning from lesions: patterns of tissue inflammation in leprosy. Proc Natl Acad Sci USA 1988, 85:1213-1217
10. Modlin RL, Brenner MB, Krangel MS, Duby AD, Bloom BR: T-cell receptors of human suppressor cells Nature 1987, 329:541-545
11. Modlin RL, Kato H, Mehra V, Nelson EE, Xue-dong F, Rea TH, Pattengale PK, Bloom BR. Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions. Nature 1986, 322.459-461
12. Longley J, Haregewoin A, Yemaneberhan T, Van Diepen TW, Nsibami J, Knowles D, Smith KA, Godal T: In vivo responses to Mycobacterium leprae: antigen presentation, interleukin-2 production, and immune cell phenotypes in naturally occurring leprosy lesions, Int J Lepr 1985, 53.385-394
13. Modlin RL, Hofman FM, Horwitz DA, Husmann LA, Gillis S, Taylor CR, Rea TH. In situ identification of cells in human leprosy granulomas with monoclonal antibodies to interleukin-2 and its receptor J Immunol 1984, 132:3085-3090
14. Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, Modlin RL: Defining protective responses to infectious pathogens cytokine profiles in leprosy lesions Science 1991, 254:277-279
15. Voic-Platzer B, Stemberger H, Luger T, Radaszkiewicz T, Wiedermann G- Defective intralesional interferon-γ activity in lepromatous leprosy Clin Exp Immunol 1988, 71:235-240
16. Arnoldi J, Gerdes J, Flad H-D: Immunohistological assessment of cytokine production of infiltrating cells in various forms of leprosy. Am J Pathol 1990, 137.749-753
17. Tsunawaki S, Sporn M, Ding A, Nathan C: Deactivation of macrophages by transforming growth factor-β Nature 1988, 334:260-262
18. Ding A, Nathan CF, Graycar J, Derynck R, Stuehr DJ, Srimal S: Macrophage deactivation factor and transforming growth factors-β1, -β2, and -β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ. J Immunol 1990, 145.940-944
19. Bogdan C, Nathan C: Modulation of macrophage function by transforming growth factor-β, interleukin-4 and interleukin-10 Ann NY Acad Sci 1993, 685:713-739
20. Barral-Neto M, Barrai A, Brownell CE, Skeiky YAW, Ellingsworth LR, Twardzik DR, Reed SG: Transforming growth factor-β in leishmanial infection: a parasite escape mechanism Science 1992, 257:545-548
21. Bermudez LE, Covaro G, Remington J: Infection of murine macrophages with Toxoplasma gondii is associated with release of transforming growth factor-β and downregulation of expression of tumor necrosis factor receptors. Infect Immun 1993, 61.4126-4130
22. Silva JS, Twardzik DR, Reed SG: Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor-β (TGF-β) J Exp Med 1991, 174 539-545
23. Bermudez LE. Production of transforming growth factor-β by Mycobacterium avium infected macrophages is associated with unresponsiveness to interieron-γ. J Immunol 1993, 150:1838-1845
24. Lotz M, Seth P: TGF-β and HIV infection. Ann NY Acad Sci 1993, 685:501-511
25. Kehrl JH, Taylor A, Kim SJ, Fauci AS: Transforming growth factor-β is a potent negative regulator of human lymphocytes. Ann NY Acad Sci 1991, 628:345-353
26. Sporn MB, Roberts AB: Transforming growth factor-β: recent progress and new challenges. J Cell Biol 1992, 119:1017-1021
27. + T cells by transforming growth factor-β1. J Immunol 1993, 151 668-677
28. Jopling WH, McDougall AC. Manual de Hanseniase. Edited by W Heinemann. London, Medical Book Ltd. 1991, pp 11-55
29. Olmsted JB: Analysis of cytoskeletal structures using blot-purified monospecific antibodies. Methods Enzymol 1986, 134.467-472
30. Salgame P, Abrams JS, Clayberger C, Goldstein H, Convit J, Modlin RL, Bloom BR: Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 1991, 254 279-282
31. Chantry D, Turner M, Abney E, Feldman M: Modulation of cytokine production by transforming growth factor-β J Immunol 1989, 142:4295-4300
32. Bogdan C, Paik J, Vodovotz Y, Nathan CF: Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interleukin-10. J Biol Chem 1992, 267 23301-23308
33. Wahl SM: Transforming growth factor-β (TGF-β) in inflammation a cause and a cure. J Clin Immunol 1992, 12:61-74
34. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman GP, Calvin D, Annunziata N, Doetschman T: Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 1992, 359:693-699
35. Kulkarni AB, Huh C-G, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S: Transforming growth factor-β1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 1993, 90:770-774
36. McCartney-Francis N, Maizel D, Wong H, Wahl L, Wahl S. TGF-β regulates production of growth factors and TGF-β by human peripheral blood monocytes. Growth Factors 1990, 4:27-35